Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,470
+220 (2.15%)
At close: Apr 8, 2026

KRX:019170 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
47,43341,98643,80041,69127,637
Short-Term Investments
24,07314,47516,24514,22664,599
Trading Asset Securities
--535.69-465.97
Cash & Short-Term Investments
71,50656,46160,58155,91792,702
Cash Growth
26.65%-6.80%8.34%-39.68%-51.37%
Accounts Receivable
72,53870,16373,66182,28981,865
Other Receivables
784.12,1558,0838,0817,860
Receivables
73,52872,52381,94590,57689,925
Inventory
58,47655,38253,92346,89547,707
Prepaid Expenses
1,2252,757766.581,008900.48
Other Current Assets
2,0012,1991,7192,1471,764
Total Current Assets
206,736189,321198,935196,542232,997
Property, Plant & Equipment
108,728115,398118,638113,760116,884
Long-Term Investments
23,08224,89621,10729,33628,571
Other Intangible Assets
5,0865,0065,7696,9318,971
Long-Term Deferred Tax Assets
1,0872,826475.256,6289,086
Other Long-Term Assets
7,7414,6335,1598,3391,841
Total Assets
352,466342,093350,084361,536398,350
Accounts Payable
7,0979,9988,94111,42812,060
Accrued Expenses
6,4079,02113,8567,3007,057
Short-Term Debt
41,19147,30545,000-248.11
Current Portion of Long-Term Debt
2,4001,400---
Current Portion of Leases
764.99951.49932.481,487719.94
Current Income Taxes Payable
300112.5118.11-133.02
Other Current Liabilities
8,7507,0567,5376,9528,332
Total Current Liabilities
66,90975,84476,38527,16728,550
Long-Term Debt
11,3744,600---
Long-Term Leases
126.18340.84218.96441.51212.67
Pension & Post-Retirement Benefits
----7,065
Other Long-Term Liabilities
3,3293,2182,6983,1692,197
Total Liabilities
81,73984,00379,30130,77838,025
Common Stock
27,59227,59227,59227,59227,592
Additional Paid-In Capital
215,780213,592213,592213,592213,592
Retained Earnings
50,77138,94355,331115,830144,925
Treasury Stock
-8,734-8,734-8,734-8,734-8,734
Comprehensive Income & Other
-15,434-14,573-18,196-18,673-18,118
Total Common Equity
269,975256,821269,586329,607359,257
Minority Interest
752.641,2691,1961,1511,067
Shareholders' Equity
270,728258,090270,782330,758360,324
Total Liabilities & Equity
352,466342,093350,084361,536398,350
Total Debt
55,85654,59746,1511,9281,181
Net Cash (Debt)
15,6501,86414,43053,98891,521
Net Cash Growth
739.66%-87.08%-73.27%-41.01%-51.54%
Net Cash Per Share
305.0236.46281.491053.181785.35
Filing Date Shares Outstanding
51.349.2749.2749.2749.27
Total Common Shares Outstanding
51.351.2651.2651.2651.26
Working Capital
139,826113,477122,550169,375204,447
Book Value Per Share
5262.545009.935258.956429.827008.22
Tangible Book Value
264,889251,814263,817322,676350,286
Tangible Book Value Per Share
5163.414912.275146.416294.626833.22
Land
15,97615,97615,97615,97615,976
Buildings
123,280121,660120,117121,946123,266
Machinery
114,296112,867103,969104,000104,224
Construction In Progress
762.971,1245,4264,231329.3
Source: S&P Global Market Intelligence. Standard template. Financial Sources.